{
  "actions": [
    {
      "acted_at": "2001-07-11T17:07:00-04:00", 
      "references": [
        {
          "reference": "CR H3918-3921", 
          "type": "consideration"
        }, 
        {
          "reference": "CR H3918-3919", 
          "type": "text"
        }
      ], 
      "text": "Amendment (A031) offered by Mr. Brown (OH).", 
      "type": "action"
    }, 
    {
      "acted_at": "2001-07-11T17:27:00-04:00", 
      "how": "by voice vote", 
      "references": [], 
      "result": "pass", 
      "text": "On agreeing to the Brown (OH) amendment (A031) Agreed to by voice vote.", 
      "type": "vote", 
      "vote_type": "vote", 
      "where": "h"
    }
  ], 
  "amendment_id": "hamdt163-107", 
  "amendment_type": "hamdt", 
  "amends_amendment": null, 
  "amends_bill": {
    "bill_id": "hr2330-107", 
    "bill_type": "hr", 
    "congress": 107, 
    "number": 2330
  }, 
  "amends_treaty": null, 
  "chamber": "h", 
  "congress": "107", 
  "description": "Amendment reallocates FDA funding of $1 million to the Office of Generic Drugs to evaluate and review potential patent abuse.", 
  "house_number": 31, 
  "introduced_at": "2001-07-11", 
  "number": 163, 
  "purpose": "An amendment to increase the funding by $1,000,000 for responsibilities of the FDA with respect to abbreviated applications for the approval of new drugs.", 
  "sponsor": {
    "district": "13", 
    "name": "Brown, Sherrod", 
    "state": "OH", 
    "thomas_id": "00136", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "pass", 
  "status_at": "2001-07-11T17:27:00-04:00", 
  "updated_at": "2013-07-17T08:15:54-04:00"
}